Can I read Pexidartinib Enhances Function in TGCT on EtoBox?
Pexidartinib Enhances Function in TGCT by tayyab qayyum is a document available to read on EtoBox.
What is Pexidartinib Enhances Function in TGCT about?
The ENLIVEN trial demonstrated that pexidartinib significantly improves physical functioning and stiffness in patients with symptomatic, advanced tenosynovial giant cell tumor (TGCT) compared to placebo, with sustained benefits observed after 50 weeks of treatment. The study utilized patient-reported outcome measures to assess improvements in physical function and stiffness, revealing a higher response rate in the pexidartinib group. Pexidartinib is an FDA-approved treatment option for patients with TGCT wh
- Author
- tayyab qayyum
- Language
- EN